Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-Label Extension of BG9924 Plus Methotrexate in Rheumatoid Arthritis
2007-000734-38Phase 2Completed
- Sponsor
- Biogen
- Start
- Jun 2007
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of baminercept in rheumatoid arthritis (RA), sponsored by Biogen. Primary endpoint: Primary safety and durability of efficacy. Started Jun 2007; status: completed.
02
Drugs
baminercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2007-000734-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000734-38.